199 related articles for article (PubMed ID: 31173881)
1. Assessment of ctDNA in CSF may be a more rapid means of assessing surgical outcomes than plasma ctDNA in glioblastoma.
Li JH; He ZQ; Lin FH; Chen ZH; Yang SY; Duan H; Jiang XB; Al-Nahari F; Zhang XH; Wang JH; Zhang GH; Zhang ZF; Li C; Mou YG
Mol Cell Probes; 2019 Aug; 46():101411. PubMed ID: 31173881
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract][Full Text] [Related]
3. Detection of mutation profiles and tumor mutation burden of cerebrospinal fluid circulating DNA by a cancer genomic panel sequencing in glioma patients.
Guo W; Jin L; Liang J; Lin G; Zheng J; Zhou D; Zhan S; Sun H; Jiang X
Clin Chim Acta; 2022 Sep; 534():81-92. PubMed ID: 35810802
[TBL] [Abstract][Full Text] [Related]
4. Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study.
Bagley SJ; Nabavizadeh SA; Mays JJ; Till JE; Ware JB; Levy S; Sarchiapone W; Hussain J; Prior T; Guiry S; Christensen T; Yee SS; Nasrallah MP; Morrissette JJD; Binder ZA; O'Rourke DM; Cucchiara AJ; Brem S; Desai AS; Carpenter EL
Clin Cancer Res; 2020 Jan; 26(2):397-407. PubMed ID: 31666247
[TBL] [Abstract][Full Text] [Related]
5. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X
Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443
[TBL] [Abstract][Full Text] [Related]
6. Assessment of circulating tumor DNA in cerebrospinal fluid by whole exome sequencing to detect genomic alterations of glioblastoma.
Duan H; Hu JL; Chen ZH; Li JH; He ZQ; Wang ZN; Zhang GH; Guo XY; Liang L; Mou YG
Chin Med J (Engl); 2020 Jun; 133(12):1415-1421. PubMed ID: 32558704
[TBL] [Abstract][Full Text] [Related]
7. Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).
Li M; Chen J; Zhang B; Yu J; Wang N; Li D; Shao Y; Zhu D; Liang C; Ma Y; Ou Q; Hou X; Chen L
BMC Med; 2022 Nov; 20(1):398. PubMed ID: 36372873
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis.
Zhao Y; He JY; Zou YL; Guo XS; Cui JZ; Guo L; Bu H
BMC Neurol; 2019 Dec; 19(1):331. PubMed ID: 31856745
[TBL] [Abstract][Full Text] [Related]
9. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages.
Yang M; Topaloglu U; Petty WJ; Pagni M; Foley KL; Grant SC; Robinson M; Bitting RL; Thomas A; Alistar AT; Desnoyers RJ; Goodman M; Albright C; Porosnicu M; Vatca M; Qasem SA; DeYoung B; Kytola V; Nykter M; Chen K; Levine EA; Staren ED; D'Agostino RB; Petro RM; Blackstock W; Powell BL; Abraham E; Pasche B; Zhang W
J Hematol Oncol; 2017 May; 10(1):100. PubMed ID: 28472989
[TBL] [Abstract][Full Text] [Related]
10. Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients.
Yamauchi M; Urabe Y; Ono A; Miki D; Ochi H; Chayama K
Int J Cancer; 2018 Apr; 142(7):1418-1426. PubMed ID: 29134647
[TBL] [Abstract][Full Text] [Related]
11. Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models.
Mair R; Mouliere F; Smith CG; Chandrananda D; Gale D; Marass F; Tsui DWY; Massie CE; Wright AJ; Watts C; Rosenfeld N; Brindle KM
Cancer Res; 2019 Jan; 79(1):220-230. PubMed ID: 30389699
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA.
Pan C; Diplas BH; Chen X; Wu Y; Xiao X; Jiang L; Geng Y; Xu C; Sun Y; Zhang P; Wu W; Wang Y; Wu Z; Zhang J; Jiao Y; Yan H; Zhang L
Acta Neuropathol; 2019 Feb; 137(2):297-306. PubMed ID: 30460397
[TBL] [Abstract][Full Text] [Related]
13. Correlation of genomic alterations between tumor tissue and circulating tumor DNA by next-generation sequencing.
Chang YS; Fang HY; Hung YC; Ke TW; Chang CM; Liu TY; Chen YC; Chao DS; Huang HY; Chang JG
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2167-2175. PubMed ID: 30203147
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC.
Wu J; Liu Z; Huang T; Wang Y; Song MM; Song T; Long G; Zhang X; Li X; Zhang L
Mol Oncol; 2023 May; 17(5):810-824. PubMed ID: 36495130
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors.
Piccioni DE; Achrol AS; Kiedrowski LA; Banks KC; Boucher N; Barkhoudarian G; Kelly DF; Juarez T; Lanman RB; Raymond VM; Nguyen M; Truong JD; Heng A; Gill J; Saria M; Pingle SC; Kesari S
CNS Oncol; 2019 Jun; 8(2):CNS34. PubMed ID: 30855176
[No Abstract] [Full Text] [Related]
16. Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma.
Fontanilles M; Deniel A; Marguet F; Beaussire L; Magne N; Derrey S; Blanchard F; Alexandru C; Coutant S; Laquerrière A; Clatot F; Di Fiore F; Sarafan-Vasseur N
Rev Neurol (Paris); 2022 Nov; 178(9):975-980. PubMed ID: 35871016
[TBL] [Abstract][Full Text] [Related]
17. Concordance analysis of cerebrospinal fluid with the tumor tissue for integrated diagnosis in gliomas based on next-generation sequencing.
Wang Q; Liang Q; Wei W; Niu W; Liang C; Wang X; Wang X; Pan H
Pathol Oncol Res; 2023; 29():1611391. PubMed ID: 37822669
[No Abstract] [Full Text] [Related]
18. Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer.
Yang J; Gong Y; Lam VK; Shi Y; Guan Y; Zhang Y; Ji L; Chen Y; Zhao Y; Qian F; Chen J; Li P; Zhang F; Wang J; Zhang X; Yang L; Kopetz S; Futreal PA; Zhang J; Yi X; Xia X; Yu P
Cell Death Dis; 2020 May; 11(5):346. PubMed ID: 32393783
[TBL] [Abstract][Full Text] [Related]
19. Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.
Yang X; Zhuo M; Ye X; Bai H; Wang Z; Sun Y; Zhao J; An T; Duan J; Wu M; Wang J
Oncotarget; 2016 Apr; 7(15):20810-24. PubMed ID: 26989078
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor DNA sequencing for colorectal cancers: A comparative analysis of colon cancer and rectal cancer data.
Huang K; Qu H; Zhang X; Huang T; Sun X; He W; Li M; Lin L; Xu M; Chen S; Xia L
Cancer Biomark; 2019; 26(3):313-322. PubMed ID: 31561327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
